Mile High Labs

It's easy to assume every Novel Food supplier is interchangeable. Same regulation, same bar, same outcome.

They're not.

The regulation is identical for everyone. What separates suppliers is what they can actually prove, and that difference is the one that shows up later in an audit, a rejected dossier, or a market you can't enter. Swipe through and connect with us for what actually sets them apart.

Quick gut check. If a clinician or program operator asked your team:

→ Can you deliver consistent bioavailability across every batch?
→ Is your bioavailability data defensible if someone asks for proof?
→ Can you support oral-only formats at a precise dose?
→ Are you positioned for healthcare-aligned programs now?
→ Are you planning on retrofitting later?

How many could you answer?

If any of those gave you pause, you're not alone. Most ingredient supply chains were built for a different era, and the standards are shifting fast.

We put together a breakdown of what's actually changing and how to evaluate where your team stands.

→ See where your supply chain stands

The Mile High Labs Global Team

The announcement has already happened.

What comes next is understanding what it may mean for the future of cannabinoid products.

The Substance Access Beneficiary Engagement Incentive (BEI) is a pilot evaluating physician-supervised, hemp-derived CBD products in a more structured, outcomes-driven environment.

It’s early. It’s limited. And it’s not broad Medicare coverage.

But it does raise an important question for brands:

If cannabinoid products move closer to healthcare-oriented pathways, is your supply chain built for that future?

That’s the conversation we believe is worth having.

See bio for full blog post.

CBC 2026 wrapped up with a lot of good conversations, familiar faces, and new connections along the way.

Grateful for everyone who stopped by the booth and took the time to connect with our team throughout the week.

Always interesting to step back and see where the industry is headed—and this year definitely brought a lot of energy and fresh ideas to the conversation.

Until next time. 🍻

We’ve been spending a lot of time lately talking with brewers about what’s next.
 
CBD beverages keep coming up — not as a trend, but as a new way to expand what’s already working.
 
We’re heading to Philadelphia next week for the Craft Brewers Conference and looking forward to continuing those conversations in person.
 
If you’re there, let’s connect.
 
____________________________
 
 
📍 Booth 433 | Craft Brewers Conference | Philadelphia | April 20–22 | Brewers Association
 
Or feel free to DM us ahead of the show — always happy to start the conversation early.